- Home
- RCMT vs KOD Comparison
RCMT vs KOD Comparison
Compare RCMT & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCMT
- KOD
- Stock Information
- Founded
- RCMT 1971
- KOD 2009
- Country
- RCMT United States
- KOD United States
- Employees
- RCMT N/A
- KOD N/A
- Industry
- RCMT Professional Services
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCMT Consumer Discretionary
- KOD Health Care
- Exchange
- RCMT Nasdaq
- KOD Nasdaq
- Market Cap
- RCMT 172.2M
- KOD 198.4M
- IPO Year
- RCMT N/A
- KOD 2018
- Fundamental
- Price
- RCMT $24.60
- KOD $4.38
- Analyst Decision
- RCMT Strong Buy
- KOD Hold
- Analyst Count
- RCMT 2
- KOD 3
- Target Price
- RCMT $33.50
- KOD $9.00
- AVG Volume (30 Days)
- RCMT 81.1K
- KOD 311.0K
- Earning Date
- RCMT 08-06-2025
- KOD 08-13-2025
- Dividend Yield
- RCMT N/A
- KOD N/A
- EPS Growth
- RCMT N/A
- KOD N/A
- EPS
- RCMT 1.74
- KOD N/A
- Revenue
- RCMT $290,914,000.00
- KOD N/A
- Revenue This Year
- RCMT $16.29
- KOD N/A
- Revenue Next Year
- RCMT $6.16
- KOD N/A
- P/E Ratio
- RCMT $14.17
- KOD N/A
- Revenue Growth
- RCMT 8.53
- KOD N/A
- 52 Week Low
- RCMT $13.18
- KOD $1.92
- 52 Week High
- RCMT $27.24
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- RCMT 55.47
- KOD 65.72
- Support Level
- RCMT $22.48
- KOD $3.70
- Resistance Level
- RCMT $27.24
- KOD $4.01
- Average True Range (ATR)
- RCMT 1.22
- KOD 0.25
- MACD
- RCMT 0.04
- KOD 0.08
- Stochastic Oscillator
- RCMT 62.07
- KOD 97.70
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.